New biologic markers in non-Hodgkin's lymphomas

T. M. Grogan; T. P. Miller

doi:10.1016/s0889-8588(18)30393-9

New biologic markers in non-Hodgkin's lymphomas

T. M. Grogan, T. P. Miller

Cancer Center

Research output: Contribution to journal › Review article

5 Scopus citations

Abstract

Recent studies suggest lymphoma surface and nuclear markers may be of both diagnostic and prognostic relevance. Specifically relevant are markers of tumor proliferation (Ki67), histocompatibility antigen (HLA), cell lineage (B versus T), and cell adhesion molecules (CD 22,44,56). Additionally, host response as measured by CD8 may be relevant to lymphoma relapse. Collectively, these tumor and host markers suggest new targets for 'phenotype-directed' therapy.

Original language	English (US)
Pages (from-to)	925-933
Number of pages	9
Journal	Hematology/Oncology Clinics of North America
Volume	5
Issue number	5
DOIs	https://doi.org/10.1016/s0889-8588(18)30393-9
State	Published - 1991

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1016/s0889-8588(18)30393-9

Fingerprint Dive into the research topics of 'New biologic markers in non-Hodgkin's lymphomas'. Together they form a unique fingerprint.

Cite this

Grogan, T. M., & Miller, T. P. (1991). New biologic markers in non-Hodgkin's lymphomas. Hematology/Oncology Clinics of North America, 5(5), 925-933. https://doi.org/10.1016/s0889-8588(18)30393-9

@article{2bac6b75c44d4c2b8b8ba114aa4657e2,

title = "New biologic markers in non-Hodgkin's lymphomas",

abstract = "Recent studies suggest lymphoma surface and nuclear markers may be of both diagnostic and prognostic relevance. Specifically relevant are markers of tumor proliferation (Ki67), histocompatibility antigen (HLA), cell lineage (B versus T), and cell adhesion molecules (CD 22,44,56). Additionally, host response as measured by CD8 may be relevant to lymphoma relapse. Collectively, these tumor and host markers suggest new targets for 'phenotype-directed' therapy.",

author = "Grogan, {T. M.} and Miller, {T. P.}",

year = "1991",

doi = "10.1016/s0889-8588(18)30393-9",

language = "English (US)",

volume = "5",

pages = "925--933",

journal = "Hematology/Oncology Clinics of North America",

issn = "0889-8588",

publisher = "W.B. Saunders Ltd",

number = "5",

}

TY - JOUR

T1 - New biologic markers in non-Hodgkin's lymphomas

AU - Grogan, T. M.

AU - Miller, T. P.

PY - 1991

Y1 - 1991

N2 - Recent studies suggest lymphoma surface and nuclear markers may be of both diagnostic and prognostic relevance. Specifically relevant are markers of tumor proliferation (Ki67), histocompatibility antigen (HLA), cell lineage (B versus T), and cell adhesion molecules (CD 22,44,56). Additionally, host response as measured by CD8 may be relevant to lymphoma relapse. Collectively, these tumor and host markers suggest new targets for 'phenotype-directed' therapy.

AB - Recent studies suggest lymphoma surface and nuclear markers may be of both diagnostic and prognostic relevance. Specifically relevant are markers of tumor proliferation (Ki67), histocompatibility antigen (HLA), cell lineage (B versus T), and cell adhesion molecules (CD 22,44,56). Additionally, host response as measured by CD8 may be relevant to lymphoma relapse. Collectively, these tumor and host markers suggest new targets for 'phenotype-directed' therapy.

UR - http://www.scopus.com/inward/record.url?scp=0025887898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025887898&partnerID=8YFLogxK

U2 - 10.1016/s0889-8588(18)30393-9

DO - 10.1016/s0889-8588(18)30393-9

M3 - Review article

C2 - 1938761

AN - SCOPUS:0025887898

VL - 5

SP - 925

EP - 933

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 5

ER -